Gut Supplements May Modestly Improve Cognition in Adults Over 60, Review Finds

THE ARISING · LONGEVITY & HEALTHSPAN SUNDAY, OCTOBER 18, 2026 IN THIS EDITION · LONGEVITY & HEALTHSPAN 1 ACOG Now Recommends Hormone Therapy for Many Women With Hot Flashes 2 Cardiologists Urge Doctors to Prescribe Exercise as Routine Heart Care 3 Fasting and Autophagy in Humans: Summary Calls Link Unproven 4 Gut Supplements May Modestly Improve Cognition in Adults Over 60, Review Finds 5 Higher Ultra-Processed Food Intake Linked to Silent Brain Damage on MRI 6 Higher VO2 Max Linked to Lower Depression and Anxiety Risk in UK Biobank 7 Bonn Lab Study Shows Blood Cells From Older Donors Lose Epigenetic Age in a Dish 8 Longer Sleep Linked to Kidney Disease Risk in Type 2 Diabetes LONGEVITY & HEALTHSPAN · WEEKLY READ · 3 MIN AGE AND AGEING · 2 SOURCES Gut Supplements May Modestly Improve Cognition in Adults Over 60, Review Finds Gut supplements are cheap, easy to find and generally low risk. A new review asks whether they might also help older adults think a little more clearly. The answer, so far, is a cautious maybe: the average signal is small, the trials differ widely, and the evidence is limited. he evidence is a systematic review and meta-analysis, published in 2026 in the journal Age and Ageing. It pools earlier trials rather than running a newT one. The team, led by Mary Ni Lochlainn at King's College London, searched four medical databases for studies of adults aged 60 and over. They found 14 that qualified. Thirteen were randomised controlled trials and one was a non- randomised interventional study. Sample sizes in the individual studies ranged from 40 to 120 people. The studies tested three kinds of product. Probiotics are live bacteria. Prebiotics are food ingredients that feed beneficial gut microbes. Synbiotics combine the two. Ten studies tested probiotics, two tested prebiotics and two tested synbiotics. THE ARISING · OCTOBER 18, 2026 PAGE 11 Participants included cognitively healthy older adults (six studies), people with mild cognitive impairment (four) and people with dementia (four). The most common length of treatment was 12 weeks, and the longest was 24 weeks. Nine of the 14 studies reported a statistically significant improvement in at least one area of thinking. The areas named were global cognition (overall mental performance), memory, attention and executive function, which covers planning and mental flexibility. This is not the same as a clean win over placebo: in one dose- comparison trial, the placebo group also improved significantly in memory. Five studies did not report improvement. Two probiotic trials, one prebiotic trial and both synbiotic trials found no significant change in any area. Six of the randomised trials used the same test, the Mini-Mental State Examination, which scores overall cognition. The authors pooled these. Compared with placebo, supplements were linked to a gain of 1.28 points on the test (95% confidence interval 0.15 to 2.40). That is statistically significant, but the range is wide. The lower end is close to no effect. The authors also report substantial heterogeneity, meaning the trials differed a lot from one another in their results. This is a modest average, not a promise for any one person. The result held up in a check that removed trials with moderate or high risk of bias. Four trials remained and the gain was 1.39 points, though the confidence interval again came close to zero (0.03 to 2.75) and the differences between trials were even larger. The authors say the evidence was strongest for global cognition, memory and executive function. They say benefits were seen more consistently in cognitively healthy older adults and those with mild cognitive impairment. What does this mean for someone considering a supplement? The review does not show that any particular product works. The trials used very different bacteria, from single strains to a mix of 18, and doses ranging from 10 million to 50 billion live organisms. The studies were small and short. The review cannot say whether effects last beyond a few months, or whether a few points on a test make a difference in daily life. It also cannot show how the supplements might act on the brain. This is where the argument is weakest: the one pooled result rests on six trials that disagree with each other, and its lower bound is barely above zero. The authors themselves describe the evidence as positive but limited by the small number of high-quality studies. Their conclusion that gut modulation "holds huge promise" is stronger than the data alone firmly support. The TwinsUK press release THE ARISING · OCTOBER 18, 2026 PAGE 12 is more measured. It quotes Ni Lochlainn as saying the findings suggest the approach "could be a promising approach to supporting cognitive health in older adults," while stressing that "more high-quality research is needed." The practical reading is simple. These products are low risk and widely available, according to the authors, and the average signal is small but positive. No one should start or stop any supplement or medication without first talking to their clinician. What to watch next: larger, well-designed trials that test specific products at set doses over longer periods, to show which ones work and for whom. Sources: Age and ageing (2026), TwinsUK / King's College London (Age and Ageing) THE ARISING · OCTOBER 18, 2026 PAGE 13